In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that ...

There’s limited scientific evidence directly linking semaglutide use to vitamin B12 deficiency or recommending routine vitamin B12 supplementation for people taking semaglutide. Semaglutide is ...

The drug is the brand-name version of the medication semaglutide. People take it as a once-weekly injection under the ... weight loss services under the Ro Body program, which combines ...

The FDA approved semaglutide injections sold under the brand name ... While yes, there are some sketchy online sites and compounding pharmacies out there that might not be selling you the real ...

April 14, 2025 — The FDA and the maker of the popular diabetes and weight loss drug Ozempic are warning people not to use counterfeit semaglutide 1.0 milligrams — the Ozempic injection ...

PLAINSBORO, N.J., March 29, 2025 /PRNewswire/ -- Novo Nordisk today presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic ® (semaglutide) injection 1 ...

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy ... in adults with a body mass index (BMI) of 27 kg/m² or greater, who have established cardiovascular disease.

A recent study from the University of Pennsylvania has shown that the injectable drug semaglutide can help people lose a large amount of weight when combined with diet and exercise. The study offers ...

Patients received either liraglutide (3.0 mg daily subcutaneous injection; n = 22) or semaglutide (1.0 mg weekly ... Primary outcomes were changes in total body weight and body mass index (BMI ...

PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ -- Novo Nordisk has become aware of several hundred units of Ozempic® (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized ...